FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065888972> ?p ?o ?g. }

• W2065888972 endingPage "1707" @default.
• W2065888972 startingPage "1701" @default.
• W2065888972 abstract "Objectives To determine the degree to which hyperglycemia predicts the development of frailty and lower extremity mobility limitations. Design Secondary data analysis of longitudinal data collected in a prospective cohort study. Setting B altimore, M aryland. Participants Three hundred twenty‐nine women from the W omen's H ealth and A ging S tudy II aged 70 to 79 at baseline who had all variables needed for analysis. Measurements Glycosylated hemoglobin ( H b A 1c) at baseline, categorized as less than 5.5%, 5.5% to 5.9%, 6.0% to 6.4%, 6.5% to 7.9%, and 8.0% and greater, was the independent variable. The incidence of frailty and lower extremity mobility limitations (based on self‐reported walking difficulty, walking speed, and S hort P erformance P hysical B attery score) was determined (follow‐up ≈ 9 years). Frailty was assessed using the C ardiovascular H ealth S tudy criteria. Covariates included demographic characteristics, body mass index, interleukin‐6 level, and clinical history of comorbidities. Statistical analyses included Kaplan–Meier survival curves and Cox regression models adjusted for important covariates. Results In time‐to‐event analyses, H b A 1c category was associated with incidence of walking difficulty ( P = .049) and low physical performance ( P = .001); association with incidence of frailty and low walking speed had a trend toward significance (both P = .10). In regression models adjusted for demographic characteristics, H b A 1c of 8.0% or greater (vs < 5.5%) was associated with an approximately three‐times greater risk of incident frailty and three to five times greater risk of lower extremity mobility limitations (all P < .05). In fully adjusted models, H b A 1c of 8.0% or greater (vs < 5.5%) was associated with incident frailty (hazard ratio ( HR ) = 3.33, 95% confidence interval ( CI ) = 1.24–8.93), walking difficulty ( HR = 3.47, 95% CI = 1.26–9.55), low walking speed ( HR = 2.82, 95% CI = 1.19–6.71), and low physical performance ( HR = 3.60, 95% CI = 1.52–8.53). Conclusion Hyperglycemia is associated with the development of frailty and lower extremity mobility limitations in older women. Future studies should identify mediators of these relationships." @default.
• W2065888972 created "2016-06-24" @default.
• W2065888972 creator A5026104189 @default.
• W2065888972 creator A5028593104 @default.
• W2065888972 creator A5037243339 @default.
• W2065888972 creator A5038943591 @default.
• W2065888972 creator A5047035896 @default.
• W2065888972 creator A5056927598 @default.
• W2065888972 creator A5079554237 @default.
• W2065888972 creator A5086987637 @default.
• W2065888972 date "2012-08-10" @default.
• W2065888972 modified "2023-10-18" @default.
• W2065888972 title "Hyperglycemia and Incidence of Frailty and Lower Extremity Mobility Limitations in Older Women" @default.
• W2065888972 cites W1485299415 @default.
• W2065888972 cites W172609984 @default.
• W2065888972 cites W2004870840 @default.
• W2065888972 cites W2020267609 @default.
• W2065888972 cites W2041107146 @default.
• W2065888972 cites W2042084120 @default.
• W2065888972 cites W2075417460 @default.
• W2065888972 cites W2079923924 @default.
• W2065888972 cites W2096466744 @default.
• W2065888972 cites W2096657471 @default.
• W2065888972 cites W2096667822 @default.
• W2065888972 cites W2101592301 @default.
• W2065888972 cites W2109982307 @default.
• W2065888972 cites W2112906476 @default.
• W2065888972 cites W2119958965 @default.
• W2065888972 cites W2122400556 @default.
• W2065888972 cites W2125421418 @default.
• W2065888972 cites W2126487639 @default.
• W2065888972 cites W2129871296 @default.
• W2065888972 cites W2131377217 @default.
• W2065888972 cites W2137138384 @default.
• W2065888972 cites W2138797833 @default.
• W2065888972 cites W2144773938 @default.
• W2065888972 cites W2152456824 @default.
• W2065888972 cites W2153229820 @default.
• W2065888972 cites W2162959968 @default.
• W2065888972 cites W2164059021 @default.
• W2065888972 cites W2166127731 @default.
• W2065888972 cites W2586645431 @default.
• W2065888972 doi "https://doi.org/10.1111/j.1532-5415.2012.04099.x" @default.
• W2065888972 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4144067" @default.
• W2065888972 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22882211" @default.
• W2065888972 hasPublicationYear "2012" @default.
• W2065888972 type Work @default.
• W2065888972 sameAs 2065888972 @default.
• W2065888972 citedByCount "117" @default.
• W2065888972 countsByYear W20658889722013 @default.
• W2065888972 countsByYear W20658889722014 @default.
• W2065888972 countsByYear W20658889722015 @default.
• W2065888972 countsByYear W20658889722016 @default.
• W2065888972 countsByYear W20658889722017 @default.
• W2065888972 countsByYear W20658889722018 @default.
• W2065888972 countsByYear W20658889722019 @default.
• W2065888972 countsByYear W20658889722020 @default.
• W2065888972 countsByYear W20658889722021 @default.
• W2065888972 countsByYear W20658889722022 @default.
• W2065888972 countsByYear W20658889722023 @default.
• W2065888972 crossrefType "journal-article" @default.
• W2065888972 hasAuthorship W2065888972A5026104189 @default.
• W2065888972 hasAuthorship W2065888972A5028593104 @default.
• W2065888972 hasAuthorship W2065888972A5037243339 @default.
• W2065888972 hasAuthorship W2065888972A5038943591 @default.
• W2065888972 hasAuthorship W2065888972A5047035896 @default.
• W2065888972 hasAuthorship W2065888972A5056927598 @default.
• W2065888972 hasAuthorship W2065888972A5079554237 @default.
• W2065888972 hasAuthorship W2065888972A5086987637 @default.
• W2065888972 hasBestOaLocation W20658889722 @default.
• W2065888972 hasConcept C120665830 @default.
• W2065888972 hasConcept C121332964 @default.
• W2065888972 hasConcept C126322002 @default.
• W2065888972 hasConcept C144024400 @default.
• W2065888972 hasConcept C149923435 @default.
• W2065888972 hasConcept C1862650 @default.
• W2065888972 hasConcept C188816634 @default.
• W2065888972 hasConcept C201903717 @default.
• W2065888972 hasConcept C2780221984 @default.
• W2065888972 hasConcept C50382708 @default.
• W2065888972 hasConcept C61511704 @default.
• W2065888972 hasConcept C70770792 @default.
• W2065888972 hasConcept C71924100 @default.
• W2065888972 hasConcept C72563966 @default.
• W2065888972 hasConcept C74909509 @default.
• W2065888972 hasConceptScore W2065888972C120665830 @default.
• W2065888972 hasConceptScore W2065888972C121332964 @default.
• W2065888972 hasConceptScore W2065888972C126322002 @default.
• W2065888972 hasConceptScore W2065888972C144024400 @default.
• W2065888972 hasConceptScore W2065888972C149923435 @default.
• W2065888972 hasConceptScore W2065888972C1862650 @default.
• W2065888972 hasConceptScore W2065888972C188816634 @default.
• W2065888972 hasConceptScore W2065888972C201903717 @default.
• W2065888972 hasConceptScore W2065888972C2780221984 @default.
• W2065888972 hasConceptScore W2065888972C50382708 @default.
• W2065888972 hasConceptScore W2065888972C61511704 @default.
• W2065888972 hasConceptScore W2065888972C70770792 @default.
• W2065888972 hasConceptScore W2065888972C71924100 @default.

• next